𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Kinetic study of CD34+ cells during peripheral blood stem cell collections

✍ Scribed by P. Bojko; W. Stellberg; C. Küdde; M. Scharifi; M. Herrmann; S. Mayer; A. Harstrick; S. Seeber


Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
76 KB
Volume
14
Category
Article
ISSN
0733-2459

No coin nor oath required. For personal study only.

✦ Synopsis


The impact of the separated volume on the yield of CD34+ cells during peripheral blood stem cell collections (PBSCC) remains controversial. We therefore studied the CD34+ cell concentration in the peripheral blood of patients (pts) during PBSCC as well as the total amount of CD34+ cells collected after each blood volume (BV) processed and engraftment data for each cycle of high dose chemotherapy (HD Ctx).

A total of 21 PBSCC from 20 patients with different malignancies were analyzed. Stem cells were mobilized by chemotherapy and G-CSF (14 pts) or GM-CSF (6 pts). Samples from the pts peripheral blood and the collection bag were taken after each BV processed and analyzed for CD34+ cells, WBC, platelets (plt), and hemoglobin (Hb). The total volume processed was two to five times the pts calculated BV (mean value 17.4 L, range 9.0-24.0 L). Sixteen pts could be evaluated for engraftment.

The mean peripheral blood CD34+ cell count was 116±103.5/l at the start of PBSCC and decreased to 57±61.6/l after processing of four times the pts BV. The mean number of CD34+ cells collected after each BV was 2.3±2.4, 5.8±5.2, 8.5±7.2, and 11.8±10.3×10 6 per kg body weight, respectively. The mean plt count decreased by 53±40.2/nl, Hb by 1.±0.5 g/dl and WBC by 0.±6.1/nl after separation of 4 BV. All but two pts reached the target value of 1.5 × 10 6 CD34+ cells/kg body weight and planned cycle of HD Ctx with 1 PBSCC. All pts engrafted and reached neutrophils>500/l and plt>20,000/l at a median of 11 and 13 days, respectively.

We could demonstrate, that the yield of CD34+ cells during PBSCC increased continuously with the volume of the separated BV and that up to 5× the patients' BV could be processed safely without serious side effects. Most pts had to undergo only 1 PBSCC to collect sufficient numbers of CD34+ cells to support sequential courses of HD Ctx without delayed engraftment.


📜 SIMILAR VOLUMES


Kinetic studies during peripheral blood
✍ Lene Meldgaard Knudsen; Kirsten Nikolaisen; Eva Gaarsdal; Hans E. Johnsen 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB

## Abstract A sufficient number of CD34+ cells in the peripheral blood stem cell product is important to achieve a rapid and sustained engraftment. The purpose of the present work was to study CD34+ cell kinetics during leukapheresis. Blood samples before and after leukapheresis were analysed for C

CD34+ collection efficiency as a functio
✍ Leonid Dubrovsky; Edward C.C. Wong; Evelio Perez-Albuerne; Brett Loechelt; Nayne 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 226 KB

## Abstract ## Purpose: To characterize the relationship between CD34^+^ collection efficiency and blood volumes processed in pediatric patients undergoing autologous peripheral blood stem cell (PBSC) collection. ## Methods: Retrospective 8‐year (2001–2009) study of pediatric patients (__n__ = 7

Collection of peripheral blood stem cell
✍ Peggy James 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB

The collection of peripheral blood stem cells by apheresis is a procedure used with increasing frequency in bone marrow transplant. The Spectra Apheresis System is an automated machine allowing the procedure to be tailored to every patient for optimal safety and comfort. The ability to constantly vi

Tempo of hematologic recovery correlates
✍ Ocean Williams; Taner Demirer; Kathy Lilleby; C. Dean Buckner; W. I. Bensinger 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 2 views

This study was undertaken to evaluate the relationship between the time to recovery of peripheral blood counts and CD34+ cells in the peripheral blood (PB) and apheresis collections of patients undergoing intensive chemotherapy followed by rhG-CSF. Twenty-three patients with a median age of 42 years

The number of CD34+ cells in peripheral
✍ A.L. Basquiera; P. Abichain; J.C. Damonte; B. Ricchi; A.G. Sturich; E.D. Palazzo 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB

The number of CD34+ cells in peripheral blood (PB) is a guide to the optimal timing to harvest peripheral blood progenitor cells (PBPC). The objective was to determine the number of CD34+ cells in PB that allows achieving a final apheresis product containing 1.5 • 10 6 CD34+ cells/kg, performing up

Collection efficiencies of MNC subpopula
✍ V. Witt; G. Fischmeister; D. Scharner; D. Printz; U. Pöttschger; G. Fritsch; H. 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB

## Abstract There is increasing demand for mononuclear cell (MNC) harvests not only for PBPC but also for immune therapies using dendritic cells and donor lymphocytes. We determined the collection efficiencies (CE) of various MNC subpopulations during CD34^+^ cell harvests using a Fenwal CS 3000 Pl